about
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaTopical therapies for the treatment of plaque psoriasis: systematic review and network meta-analysesComparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screeningTrial-based cost-effectiveness analysis comparing surgical and endoscopic drainage in patients with obstructive chronic pancreatitis.Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trialsEconomic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics.A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care.Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence: involvement of the orthopaedic surgical panel.The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis.A Cost-effectiveness Analysis of Surgery, Endothermal Ablation, Ultrasound-guided Foam Sclerotherapy and Compression Stockings for Symptomatic Varicose Veins.Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis.Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.Acupuncture in mainstream health care.Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.Nice Clinical Guideline on Managing Faecal Incontinence: Evidence of the Effectiveness and Cost-Effectiveness of Surgical Interventions.Diagnosis and Management of Iron Deficiency in CKD: A Summary of the NICE Guideline Recommendations and Their Rationale.National Clinical Guideline Centre cost-effectiveness assessment for the National Institute for Health and Clinical Excellence.Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulationEconomic analysis of a pragmatic randomised trial of home visits by a nurse to elderly people with hypertension in MexicoLaparoscopic donor nephrectomy: is it cost effective? Perspective from health economistsEarly identification and management of chronic kidney disease in adults: summary of updated NICE guidanceA Cost-Effectiveness Analysis Of Interventions For Symptomatic Varicose VeinsCost effectiveness of health checks
P50
Q24528552-B4D15B26-C605-42DF-BBE3-DC5C855F0034Q27003961-744F1A65-0D94-429E-B881-5E7B75A0006DQ28187932-3A463419-DFB2-40C6-915A-C6DBE1076438Q30547712-648890A1-B7E0-422D-B3F7-5039AD6F334BQ34210937-42CECE7C-9C9F-477F-AE89-E4CC2C5ACF90Q34563933-56EF288C-3757-4F37-8EA0-154FCB902854Q35064567-BDD10886-4812-4826-9F75-171D8B6CD997Q35939934-2E9FC53C-DB9D-497B-953D-52EFDBE985D6Q36598609-342010D9-C3FC-47C1-92E9-C0D1A9958777Q36598627-51727E15-9603-4698-BC77-61DA3B481BECQ36623431-32EAC884-51F6-4F8E-A8CD-8F3A6442A94AQ36695547-C063A227-62B9-4885-BC64-75401458CBE5Q37268515-E324E9B9-2726-4203-901F-39402E60D8CCQ37740803-C8FF4897-B5A0-421D-B48E-08F3C7486B3CQ37964152-F031CBC3-04D2-48EB-A5E0-86CA86C07F5CQ38598452-073110D5-6FD6-411A-BABC-67B70EB86E0AQ39070719-558815F7-2065-4672-B2B1-1B50B87F2DC9Q39260883-225E813D-1E3E-4D73-B522-1998EFE78151Q41585693-146C1AE8-6211-469C-B090-6859D215452CQ43252591-7267DEA8-AF1F-40D8-B033-1EDA7933213FQ45928983-1C7B78D5-86BB-43A0-834D-41D54E37CB00Q46873751-095A2AAC-8B92-4338-A4F2-794CEFA5896BQ47915626-F229FFF7-0168-4099-BD94-886826ED9D61Q51028860-93E31BA5-B293-4DDC-BF4E-57B2D56491C7Q51839068-BA64B4F0-C336-4416-8611-9DEEDC462B99Q73282223-D5F04C8F-3CDA-465B-A2D5-EF4FD7C79AC2Q77811930-BE5094CC-2AFA-4889-A48A-2A7E4491E4F1Q80521393-E757A9AB-3B2C-49BB-A030-5FE7DFD53589Q87439389-3C4B3316-2252-4E6F-B3AD-2958FDFCCA09Q89240984-36A1F406-A6C9-4454-B155-F74689E5C86FQ94322964-2341BB41-39D3-4A88-9787-259941FD5DB5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Wonderling
@ast
David Wonderling
@en
David Wonderling
@es
David Wonderling
@nl
David Wonderling
@sl
type
label
David Wonderling
@ast
David Wonderling
@en
David Wonderling
@es
David Wonderling
@nl
David Wonderling
@sl
prefLabel
David Wonderling
@ast
David Wonderling
@en
David Wonderling
@es
David Wonderling
@nl
David Wonderling
@sl
P106
P21
P31
P496
0000-0003-0315-6273